ReP USP - Resultado da busca

Artigo de periodico
Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs (2022)
Roquini, Daniel B.; Silva, Gabriel L.; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Wilairatana, Polrat; Moraes, Josué de
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: HELMINTÍASE, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROQUINI, Daniel B. et al. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, v. 13, p. 901459-1-901459-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.901459. Acesso em: 30 set. 2024.
APA
Roquini, D. B., Silva, G. L., Ferreira, L. L. G., Andricopulo, A. D., Wilairatana, P., & Moraes, J. de. (2022). Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, 13, 901459-1-901459-9. doi:10.3389/fphar.2022.901459
NLM
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Vancouver
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Artigo de periodico
Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics (2022)
Pauli, Ivani; Rezende Junior, Celso de Oliveira ; Slafer, Brian W.; Dessoy, Marco A.; Souza, Mariana Laureano de ; Ferreira, Leonardo Luiz Gomes ; Adjanohun, Abraham L. M.; Ferreira, Rafaela S.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Duarte, Simone Michelan ; Del Pintor, Ricardo Vaz; Silva, Fernando B. R. da; Cruz, Fabio C.; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULI, Ivani et al. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, v. 12, n. Ja 2022, p. 774069-1-774069-21 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.774069. Acesso em: 30 set. 2024.
APA
Pauli, I., Rezende Junior, C. de O., Slafer, B. W., Dessoy, M. A., Souza, M. L. de, Ferreira, L. L. G., et al. (2022). Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, 12( Ja 2022), 774069-1-774069-21 + supplementary material. doi:10.3389/fphar.2021.774069
NLM
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Vancouver
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Artigo de periodico-carta/editorial
Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial] (2022)
Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2022.945747. Acesso em: 30 set. 2024. , 2022
APA
Ferreira, L. L. G., & Andricopulo, A. D. (2022). Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.3389/fphar.2022.945747
NLM
Ferreira LLG, Andricopulo AD. Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial] [Internet]. Frontiers in Pharmacology. 2022 ; 13 945747-1-945747-3.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2022.945747
Vancouver
Ferreira LLG, Andricopulo AD. Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial] [Internet]. Frontiers in Pharmacology. 2022 ; 13 945747-1-945747-3.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2022.945747
Monografia/livro-ed/org
Chemoinformatics approaches to structure- and ligand-based drug design (2019)
Andricopulo, Adriano Defini (Editor) ; Ferreira, Leonardo Luiz Gomes (Editor)
Unidade: IFSC
Subjects: MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS, QUÍMICA FARMACÊUTICA, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chemoinformatics approaches to structure- and ligand-based drug design. . Lausanne: Frontiers Media. Disponível em: https://doi.org/10.3389/978-2-88945-744-1. Acesso em: 30 set. 2024. , 2019
APA
Chemoinformatics approaches to structure- and ligand-based drug design. (2019). Chemoinformatics approaches to structure- and ligand-based drug design. Lausanne: Frontiers Media. doi:10.3389/978-2-88945-744-1
NLM
Chemoinformatics approaches to structure- and ligand-based drug design [Internet]. 2019 ;[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/978-2-88945-744-1
Vancouver
Chemoinformatics approaches to structure- and ligand-based drug design [Internet]. 2019 ;[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/978-2-88945-744-1
Artigo de periodico-carta/editorial
Chemoinformatics approaches to structure- and ligand-based drug design. [Editorial] (2018)
Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Chemoinformatics approaches to structure- and ligand-based drug design. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2018.01416. Acesso em: 30 set. 2024. , 2018
APA
Ferreira, L. L. G., & Andricopulo, A. D. (2018). Chemoinformatics approaches to structure- and ligand-based drug design. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.3389/fphar.2018.01416
NLM
Ferreira LLG, Andricopulo AD. Chemoinformatics approaches to structure- and ligand-based drug design. [Editorial] [Internet]. Frontiers in Pharmacology. 2018 ; 9 1416-1-1416-2.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2018.01416
Vancouver
Ferreira LLG, Andricopulo AD. Chemoinformatics approaches to structure- and ligand-based drug design. [Editorial] [Internet]. Frontiers in Pharmacology. 2018 ; 9 1416-1-1416-2.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2018.01416
Artigo de periodico
Chemoinformatics strategies for leishmaniasis drug discovery (2018)
Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: QUÍMICA MÉDICA, TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Chemoinformatics strategies for leishmaniasis drug discovery. Frontiers in Pharmacology, v. No 2018, p. 1278-1-1278-11, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.01278. Acesso em: 30 set. 2024.
APA
Ferreira, L. L. G., & Andricopulo, A. D. (2018). Chemoinformatics strategies for leishmaniasis drug discovery. Frontiers in Pharmacology, No 2018, 1278-1-1278-11. doi:10.3389/fphar.2018.01278
NLM
Ferreira LLG, Andricopulo AD. Chemoinformatics strategies for leishmaniasis drug discovery [Internet]. Frontiers in Pharmacology. 2018 ; No 2018 1278-1-1278-11.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2018.01278
Vancouver
Ferreira LLG, Andricopulo AD. Chemoinformatics strategies for leishmaniasis drug discovery [Internet]. Frontiers in Pharmacology. 2018 ; No 2018 1278-1-1278-11.[citado 2024 set. 30 ] Available from: https://doi.org/10.3389/fphar.2018.01278
Artigo de periodico
Molecular docking and structure-based drug design strategies (2015)
Ferreira, Leonardo Luiz Gomes ; Santos, Ricardo N.; Oliva, Glaucius ; Andricopulo, Adriano Defini
Source: Molecules. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes et al. Molecular docking and structure-based drug design strategies. Molecules, v. 20, n. 7, p. 13384-13421, 2015Tradução . . Disponível em: https://doi.org/10.3390/molecules200713384. Acesso em: 30 set. 2024.
APA
Ferreira, L. L. G., Santos, R. N., Oliva, G., & Andricopulo, A. D. (2015). Molecular docking and structure-based drug design strategies. Molecules, 20( 7), 13384-13421. doi:10.3390/molecules200713384
NLM
Ferreira LLG, Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies [Internet]. Molecules. 2015 ; 20( 7): 13384-13421.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/molecules200713384
Vancouver
Ferreira LLG, Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies [Internet]. Molecules. 2015 ; 20( 7): 13384-13421.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/molecules200713384
Artigo de periodico
Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors (2012)
Laine, Élodie; Martínez, Leandro; Ladant, Daniel; Malliavin, Thérèse; Blondel, Arnaud
Source: Toxins. Unidade: IFSC
Subjects: MODELAGEM MOLECULAR, TOXINAS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAINE, Élodie et al. Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors. Toxins, v. 4, n. 8, p. 580-604, 2012Tradução . . Disponível em: https://doi.org/10.3390/toxins4080580. Acesso em: 30 set. 2024.
APA
Laine, É., Martínez, L., Ladant, D., Malliavin, T., & Blondel, A. (2012). Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors. Toxins, 4( 8), 580-604. doi:10.3390/toxins4080580
NLM
Laine É, Martínez L, Ladant D, Malliavin T, Blondel A. Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors [Internet]. Toxins. 2012 ; 4( 8): 580-604.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/toxins4080580
Vancouver
Laine É, Martínez L, Ladant D, Malliavin T, Blondel A. Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors [Internet]. Toxins. 2012 ; 4( 8): 580-604.[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/toxins4080580

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Grupo de pesquisa

Funding Agencies

Non normalized affiliation